Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for non-specific autoimmune supratentorial encephalitis with characteristic antibodies has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for non-specific autoimmune supratentorial encephalitis with characteristic antibodies.
4 publications have been identified in PubMed for non-specific autoimmune supratentorial encephalitis with characteristic antibodies. Research spans Diagnostic / Biomarker (25%), Review / Meta-Analysis (25%), and Case Report / Case Series (25%).
Gilligan M (2025). [PMID: 39708293](https://pubmed.ncbi.nlm.nih.gov/39708293/). *Annals of clinical and translational neurology*. [Case Report / Case Series]
Saeed S (2025). [PMID: 40611612](https://pubmed.ncbi.nlm.nih.gov/40611612/). *Annals of medicine*. [Review / Meta-Analysis]
Villanueva-Castro E (2025). [PMID: 40502879](https://pubmed.ncbi.nlm.nih.gov/40502879/). *Cureus*. [Epidemiology / Natural History]
Sanvito F (2024). [PMID: 38507081](https://pubmed.ncbi.nlm.nih.gov/38507081/). *Neuroradiology*. [Diagnostic / Biomarker]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 4:52 AM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
European rare disease database
Genetic and Rare Diseases Info Center